TriAgenics is a medica device company that manufactures instruments for blocking the formation of wisdom teeth.
Triagenics has raised $3.0M in total funding. The most recent round was Series B. The last funding was announced in July 2025.
Triagenics's investors include Asclepius Ventures.
Triagenics is headquartered in Redmond, United States.
TriAgenics is a medica device company that manufactures instruments for blocking the formation of wisdom teeth.
Triagenics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Triagenics — Funding & Investors." VCBacked, July 16, 2025, https://www.vcbacked.co/company/triagenics. Accessed August 1, 2026.
VCBacked. (2025). Triagenics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/triagenics
{{cite web |title=Triagenics — Funding & Investors |url=https://www.vcbacked.co/company/triagenics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated